Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Elysee Development (PK) Charts. Click Here for more Elysee Development (PK) Charts.](/p.php?pid=staticchart&s=NO%5EASXSF&p=8&t=15)
Remedent, Inc. (OTCBB: REMI), an international company
specializing in oral care and cosmetic dentistry products, and renowned
cosmetic dentist Dr. Cyrus Tahmesebi, today announced the launch of
GlamTech USA, Inc., a strategic marketing group dedicated to making
GlamSmile™ the #1 veneer system in America.
The Remedent/GlamTech alliance will significantly lessen time-to-market
for the GlamSmile™ product in the world’s
largest dental market while allowing Remedent to better allocate
resources to global markets, product development, and manufacturing and
distribution enhancements.
Led by CEO Dr. Tahmesebi, GlamTech brings together substantial capital
and expertise around the single goal of dominating the domestic veneer
marketplace. GlamTech will focus on building dentist and consumer
interest in GlamSmile™ through trade and
consumer advertising, direct marketing, and strategic alliances.
Under the terms of a distribution agreement between the two companies,
GlamTech has exclusive rights to market and distribute Remedent’s
GlamSmile™ veneers in the United States and
Canada.
GlamTech’s seven-figure commitment includes a
significant license fee and agreement to purchase a sizable minimum
number of veneer trays annually. In order to maintain its exclusive
distributorship, the agreement also calls for incremental yearly
Glamsmile™ veneer tray purchases of a minimum
of 15% over prior year's minimums.
Dr. Tahmesebi operates cosmetic dental practices in Southern California,
is a guest lecturer at the University of Southern California Dental
School, and has appeared on numerous television network shows on dental
matters. Until recently he was the Medical and Dental Director of
BriteSmile. GlamTech President, Roger Leddington, has 17 years
experience launching innovative dental technologies and products within
domestic and international markets. Mr. Leddington guided GlamSmile's
entry into the US market late last year and, in conjunction with the
GlamTech distribution agreement, is resigning his position as Senior
Vice President and Head of US Marketing for Remedent in order to accept
the position as GlamTech’s President.
Mr. Guy De Vreese, Chairman of Remedent, noted, “The
United States is the #1 dental market in the world and this relationship
means an increased speed-to-market due to our distributor's significant
marketing capability. Our exclusive distributorship with Dr. Tahmesebi
and GlamTech creates a very strong foundation for penetrating the US
dental market and accelerating continuing revenue streams from GlamSmile™
sales while, at the same time, providing Remedent with improved capital
structure for its global expansion and product development.”
GlamTech CEO Dr. Tahmesebi stated, “GlamSmile
represents a very exciting opportunity for every dentist and millions of
consumers in the United States and Canada. Building on Remedent’s
initial introduction of GlamSmile, GlamTech plans a broad-based advance
of that launch to educate clinicians and consumers about the very
compelling professional and personal advantages of this extraordinary
product.”
About Remedent, Inc.
Remedent, Inc., a publicly-traded company on the OTCBB,
specializes in the research, development, manufacturing and marketing of
oral care and cosmetic dentistry products. With offices in California,
Belgium and Singapore, Remedent distributes its products in more than 35
countries. For additional information, visit Remedent's web site at www.remedent.com.
FORWARD-LOOKING STATEMENTS
“Safe Harbor”
Statement under the Private Securities Litigation Reform Act of 1995:
The statements by Guy De Vreese, the statements regarding growth of the
Glamsmile™ product line, optimism related to
the business, expanding sales, the U.S. and international markets and
other statements in this press release are forward-looking statements
within the meaning of the Securities Litigation Reform Act of 1995. Such
statements are based on current expectations, estimates and projections
about the Company’s business. Words such as
expects, anticipates, intends, plans, believes, sees, estimates and
variations of such words and similar expressions are intended to
identify such forward-looking statements. These statements are not
guarantees of future performance and involve certain risks and
uncertainties that are difficult to predict. Actual results could vary
materially from the description contained herein due to many factors
including continued market acceptance of the Company’s
products. In addition, actual results could vary materially based on
changes or slower growth in the oral care and cosmetic dentistry
products market; the potential inability to realize expected benefits
and synergies; domestic and international business and economic
conditions; changes in the dental industry; unexpected difficulties in
penetrating the oral care and cosmetic dentistry products market;
changes in customer demand or ordering patterns; changes in the
competitive environment including pricing pressures or technological
changes; technological advances; shortages of manufacturing capacity;
future production variables impacting excess inventory and other risk
factors listed from time to time in the Company’s
Securities and Exchange Commission filings under “risk
factors” and elsewhere. The forward-looking
statements contained in this press release speak only as of the date on
which they are made, and the Company does not undertake any obligation
to update any forward-looking statement to reflect events or
circumstances after the date of this press release.